PEBL, a component-based Chinese medicine, reduces virus-induced acute lung injury by targeting FXR to decrease ACE2 levels
Liling Yang, Xiangjun Zhou, Junshan Liu, Guangli Yang, Weifu Tan, Hongyan Ding, Xiaochuan Fang, Jingtao Yu, Wei Li, Jiayang He, Huihui Cao, Qinhai Ma, Linzhong Yu, Zibin Lu
:
Journal of Advanced Research